Bulls N' Bears with Matt BirneyBulls N' Bears with Matt Birney

Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?

View descriptionShare

Bulls N' Bears with Matt Birney

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers pu 
511 clip(s)
Loading playlist

Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer? 

Listen to ASX-listed Clarity Pharmaceuticals Executive Chair Alan Taylor talk to Matt Birney on the Bulls N’ Bears Report about Clarity’s amazing clinical trial results that saw a complete response in one patient and lots with a 90 per cent plus reduction in signs of prostate cancer using “copper” based radiopharmaceuticals.

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. Bulls N' Bears with Matt Birney

    511 clip(s)

Bulls N' Bears with Matt Birney

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Per 
Social links
Follow podcast
Recent clips
Browse 515 clip(s)